Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1998
12/15/1998US5849860 Polyethylene-protein conjugates
12/15/1998US5849719 Method for treating allergic lung disease
12/15/1998US5849599 Method for making a preconjugate
12/15/1998US5849575 Cloning and expression of host-protective immunogens of IBDV
12/15/1998US5849562 Production of complementary DNA representing hepatitis A viral sequences by recombinant DNA methods and uses therefor
12/15/1998US5849555 Valyl trna polynucleotides from Streptococcus pneumoniae
12/15/1998US5849533 Method for making unclipped HIV envelope protein
12/15/1998US5849531 Compositions and treatments for pneumonia in animals
12/15/1998US5849530 Manipulation of gene copy number in bordetella
12/15/1998US5849517 Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
12/15/1998US5849509 Nuclear matrix proteins
12/15/1998US5849507 Methods to diagnose thrombosis by measuring activation peptide
12/15/1998US5849506 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/15/1998US5849485 Liver enriched transcription factor
12/15/1998US5849476 Recombinant varicella-zoster virus and process for constructing same
12/15/1998US5849307 Vaccine adjuvant
12/15/1998US5849306 Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
12/15/1998US5849305 Construction of Pasteurella haemolytica vaccines
12/15/1998US5849304 Recombinant vaccinia virus expressing human retrovirus gene
12/15/1998US5849303 Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
12/15/1998US5849301 Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents
12/15/1998US5849299 Attenuated revertant serotype 1 marek's disease vaccine
12/15/1998US5849298 Treatment of multiple sclerosis by oral administration of bovine myelin
12/15/1998US5849297 Modified human C3 proteins
12/15/1998US5849295 Nucleotide sequences coding for a protein with urease activity
12/15/1998US5849290 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/15/1998CA2091886C Multiple promoter baculovirus expression system and defective particle production
12/15/1998CA1340245C Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same
12/15/1998CA1340243C Recombinant marek's disease virus and a vaccine
12/15/1998CA1340233C Antigenic epitopes of immunoglobulin e present on b cell but not basophil surface
12/15/1998CA1340213C Antigens of plasmodium falciparum
12/15/1998CA1340211C A method of inactivating a lipid-enveloped virus in a therapeutic solution
12/15/1998CA1340203C Recombinant apivoxvirus
12/15/1998CA1340202C Method to control leukocyte extravasation
12/15/1998CA1340201C Receptors for immune complexes
12/15/1998CA1340196C Immunodiagnostic method for neurocysticercosis
12/15/1998CA1340183C Immunologically active whey fraction and recovery process
12/13/1998CA2234424A1 Novel compounds
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055627A1 Mutant measles virus antigens and genes encoding the same
12/10/1998WO1998055626A2 Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
12/10/1998WO1998055624A1 Bacterial pheromones and uses therefor
12/10/1998WO1998055621A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055620A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055619A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998WO1998055618A1 Mitofusin genes and their uses
12/10/1998WO1998055617A1 Translational regulator initiation factor 4e-binding protein
12/10/1998WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998WO1998055613A1 Zinc ring protein
12/10/1998WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity
12/10/1998WO1998055607A2 Tumor targeted vector
12/10/1998WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998WO1998055511A1 Novel canine cytokine protein
12/10/1998WO1998055501A1 Improved method for site-selective glycosylation
12/10/1998WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998WO1998055154A1 Radioprotectant for peptides labeled with radioisotope
12/10/1998WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998WO1998055142A1 Methods for treating thrombotic disorders
12/10/1998WO1998055133A1 A melanoma associated antigen, t cell epitopes thereof and methods of using same
12/10/1998WO1998041188A3 Stable particle in liquid formulations
12/10/1998WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
12/10/1998WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants
12/10/1998WO1998022575A3 Nucleotide sequence of escherichia coli pathogenicity islands
12/10/1998WO1998014216A3 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2293429A1 Methods for treating thrombotic disorders
12/10/1998CA2292899A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998CA2292891A1 Zinc ring protein
12/10/1998CA2292840A1 Mitofusin genes and their uses
12/10/1998CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998CA2292835A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292760A1 Vector
12/10/1998CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998CA2290987A1 Radioprotectant for peptides labeled with radioisotope
12/10/1998CA2234423A1 Processes for preparation of marek's disease virus using continuous mammalian cell lines
12/10/1998CA2234411A1 Novel compounds
12/09/1998EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same
12/09/1998EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998EP0882794A2 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882453A2 Methods for treating thrombotic disorders
12/09/1998EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization
12/09/1998EP0882132A2 A human cytomegalovirus combined antigen and its use
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0882129A1 Recombinant expression of s-layer proteins
12/09/1998EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
12/09/1998EP0881911A1 Immunogenic complex, iscom, for use in preparing a vaccine for juvenile individuals
12/09/1998EP0881910A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
12/09/1998EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/09/1998EP0881884A1 Bacterial delivery system
12/09/1998EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN1201493A Materials and methods relating to attachment and display of substances on cell surfaces
12/09/1998CN1201492A Cell-cycle checkpoint genes
12/09/1998CN1201464A Helicobacter pylori protein
12/09/1998CN1201396A Influenza vaccine compositions
1 ... 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 ... 1823